IL6 and metabolic dysfunction-associated steatohepatitis: Wieckowska and coworkers demonstrated a markedly increased hepatic IL-6 expression assayed with immunohistochemistry in patients with non-alcoholic steatohepatitis, as compared to normal liver, and found hepatic IL-6 expression to be correlated with the severity of inflammation and fibrosis [31].